Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sustained OnabotulinumtoxinA in Chronic Migraine
NCT03606356Phase 4Completed
- Sponsor
- Corfu Headache Clinic
- Start
- Apr 2015
- Primary completion
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of botulinum toxin type A in chronic migraine, sponsored by Corfu Headache Clinic. Started Apr 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT03606356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03606356.